Toralgen
1 known investors
Toralgen is a preclinical-stage biopharmaceutical company developing an oral nanoparticle drug delivery platform ("nanopill") designed to protect drugs, including biologics, through the digestive tract and release them into circulation at the intestinal wall. It is developing human therapeutics, currently focused on treatments for diabetes and autoimmune disorders.
BiotechDeep TechHealthtech